Literature DB >> 15644998

Preliminary evidence for an association between aggressive and hostile behaviour and 3alpha,5alpha-tetrahydroprogesterone plasma levels in schizophrenia.

Gianfranco Spalletta1, Elena Romeo, Giuseppina Bonaviri, Giorgio Bernardi, Carlo Caltagirone, Flavia di Michele.   

Abstract

OBJECTIVE: Because it has been suggested that agents acting on the gamma-aminobutyric acid-A (GABA(A)) receptor complex, such as the neuroactive steroid 3!#!alpha;,5alpha-tetrahydroprogesterone (3alpha,5alpha-THP), may be biologic modulators of aggression, we aimed to measure 3alpha,5alpha-THP plasma concentrations in subjects with schizophrenia in order to investigate a possible relation with aggressive and hostile behaviour.
METHODS: Eight outpatients with schizophrenia diagnosed according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV), were included. Aggression and hostility were assessed using the Modified Overt Aggression Scale and the paranoid/belligerence symptom cluster of the Positive and Negative Syndrome Scale. Plasma samples were obtained 1 hour before psychometric assessment and were quantified for 3alpha,5alpha-THP using a highly sensitive and specific combined analysis by gas chromatography-mass spectrometry.
RESULTS: Increased aggressiveness and hostility were associated with increased 3alpha,5alpha-THP plasma levels (Pearson r = 0.72, p = 0.043 and Pearson r = 0.72, p = 0.041, respectively).
CONCLUSIONS: These preliminary results suggest that the neuroactive steroid 3alpha,5alpha-THP may affect aggression and hostility in humans.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15644998      PMCID: PMC543841     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  30 in total

1.  Olanzapine increases allopregnanolone in the rat cerebral cortex.

Authors:  C E Marx; G E Duncan; J H Gilmore; J A Lieberman; A L Morrow
Journal:  Biol Psychiatry       Date:  2000-06-01       Impact factor: 13.382

2.  Alcohol, allopregnanolone and aggression in mice.

Authors:  E W Fish; S Faccidomo; J F DeBold; K A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2001-02       Impact factor: 4.530

3.  Profiling neurosteroids in cerebrospinal fluids and plasma by gas chromatography/electron capture negative chemical ionization mass spectrometry.

Authors:  Y S Kim; H Zhang; H Y Kim
Journal:  Anal Biochem       Date:  2000-01-15       Impact factor: 3.365

4.  Flunitrazepam (Rohypnol) abuse in combination with alcohol causes premeditated, grievous violence in male juvenile offenders.

Authors:  A M Dåderman; L Lidberg
Journal:  J Am Acad Psychiatry Law       Date:  1999

5.  Involvement of GABAergic neurotransmission in the neurobiology of the apomorphine-induced aggressive behavior paradigm, a model of psychotic behavior in rats.

Authors:  R Rudissaar; K Pruus; T Skrebuhhova-Malmros; L Allikmets; V Matto
Journal:  Methods Find Exp Clin Pharmacol       Date:  2000-10

6.  Paranoid/belligerence and neuroleptic dosage in newly admitted schizophrenic patients.

Authors:  A Troisi; A Pasini; F de Angelis; G Spalletta
Journal:  J Clin Psychopharmacol       Date:  1997-04       Impact factor: 3.153

7.  Suppressing aggressive behavior with analogs of allopregnanolone (epalon).

Authors:  B Slavíková; A Kasal; L Uhlírová; M Krsiak; H Chodounská; L Kohout
Journal:  Steroids       Date:  2001-02       Impact factor: 2.668

Review 8.  The Expert Consensus Guideline Series. Treatment of behavioral emergencies.

Authors:  M H Allen; G W Currier; D H Hughes; M Reyes-Harde; J P Docherty
Journal:  Postgrad Med       Date:  2001-05       Impact factor: 3.840

9.  Plasma GABA levels correlate with aggressiveness in relatives of patients with unipolar depressive disorder.

Authors:  J M Bjork; F G Moeller; G L Kramer; M Kram; A Suris; A J Rush; F Petty
Journal:  Psychiatry Res       Date:  2001-03-25       Impact factor: 3.222

10.  Alcohol and heightened aggression in individual mice.

Authors:  K A Miczek; H M Barros; L Sakoda; E M Weerts
Journal:  Alcohol Clin Exp Res       Date:  1998-11       Impact factor: 3.455

View more
  4 in total

Review 1.  Action by and sensitivity to neuroactive steroids in menstrual cycle related CNS disorders.

Authors:  Anna-Carin N-Wihlbäck; Inger Sundström-Poromaa; Torbjörn Bäckström
Journal:  Psychopharmacology (Berl)       Date:  2005-12-15       Impact factor: 4.530

Review 2.  Neurobiology of aggression and violence in schizophrenia.

Authors:  Michael Soyka
Journal:  Schizophr Bull       Date:  2011-09       Impact factor: 9.306

Review 3.  The relevance of neuroactive steroids in schizophrenia, depression, and anxiety disorders.

Authors:  Erin M MacKenzie; John Odontiadis; Jean-Michel Le Mellédo; Trevor I Prior; Glen B I Baker
Journal:  Cell Mol Neurobiol       Date:  2007-08       Impact factor: 5.046

4.  Dentine sensitivity risk factors: A case-control study.

Authors:  Ana Cristina Mafla; Luis Fernando Lopez-Moncayo
Journal:  Eur J Dent       Date:  2016 Jan-Mar
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.